Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533859 | PMC |
| http://dx.doi.org/10.1177/2396987319834772 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pursuing Equity With Artificial Intelligence in Health Care.
JAMA Health Forum
January 2025
Microsoft, Redmond, Washington.
Operating in the realm of uncertainty: the "Fear Factor".
Updates Surg
January 2025
Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study.
J Endocrinol Invest
January 2025
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Via Rita Levi Montalcini 4, Milan, Italy.
Purpose: The real-world effectiveness of switching from denosumab to romosozumab remains controversial. Sequential therapy with romosozumab was shown to be associated with inadequate suppression of bone resorption and there was anecdotal evidence of major osteoporotic fractures (MOFs) after transitioning from denosumab to romosozumab. This study evaluated the effects on bone resorption of early romosozumab administration 3 months after denosumab withdrawal in fractured women with post-menopausal osteoporosis.
View Article and Find Full Text PDF[The importance of health care research for the medical community from the perspective of the German Pain Society].
Schmerz
February 2025
Alt-Moabit 101b, Deutsche Schmerzgesellschaft e. V., 10559, Berlin, Deutschland.
[Interprofessional healthcare research-Now integral component of pain research].
Schmerz
February 2025
Institut für Pflegewissenschaft und -praxis, Paracelsus Medizinische Universität, Strubergasse 21, 5020, Salzburg, Österreich.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!